Regression of asymptomatic intracranial arterial stenosis by aggressive medical management with a lipid-lowering agent
Bo Seok Kim, Jun Seob Lim, Jae Uk Jeong, Jong Hyun Mun, Sung Hyun Kim
J Cerebrovasc Endovasc Neurosurg. 2019;21(3):144-151.   Published online 2019 Sep 30     DOI: https://doi.org/10.7461/jcen.2019.21.3.144
Citations to this article as recorded by Crossref logo
Optimal Medical Management of Atherosclerotic Intracranial Stenosis
Ashley M. Wabnitz, Tanya N. Turan
Stroke.2024; 55(2): 335.     CrossRef
Focused Update on Intracranial Atherosclerosis: Introduction, Highlights, and Knowledge Gaps
Brian L. Hoh, Marc I. Chimowitz
Stroke.2024; 55(2): 305.     CrossRef
Lipid Levels and Short-Term Risk of Recurrent Brain Infarcts in Symptomatic Intracranial Stenosis
Shyam Prabhakaran, David S. Liebeskind, George Cotsonis, Azhar Nizam, Edward Feldmann, Rajbeer S. Sangha, Iszet Campo-Bustillo, Jose G. Romano
Journal of Stroke and Cerebrovascular Diseases.2022; 31(1): 106141.     CrossRef
Asymptomatic Intracranial Atherosclerotic Stenosis
Tanya N. Turan, Kimberly P. Kicielinski
Journal of the American College of Cardiology.2021; 78(6): 572.     CrossRef